ISOLUTE® 101 is a non-polar polymeric (PS-DVB) phase for extraction of polar analytes from aqueous samples.
ISOLUTE® 101 is an unmodified polystyrene-divinylbenzene copolymer, for extraction of a range of polar analytes from aqueous samples using a non-polar retention mechanism.
No secondary interactions are present, so pure elution solvents can be used.
Part No. | Description | Pack Size | List Price | |
---|---|---|---|---|
101-0010-B | ISOLUTE® 101 100 mg/3 mL | 50 | 130 USD | Add to quote/cart |
101-0020-B | ISOLUTE® 101 200 mg/3 mL | 50 | 204 USD | Add to quote/cart |
101-0020-C | ISOLUTE® 101 200 mg/6 mL | 30 | 133 USD | Add to quote/cart |
101-0002-A | ISOLUTE® 101 25 mg/1 mL | 100 | 147 USD | Add to quote/cart |
101-0027-D | ISOLUTE® 101 270 mg/15 mL | 20 | 123 USD | Add to quote/cart |
101-0050-B | ISOLUTE® 101 500 mg/3 mL | 50 | 423 USD | Add to quote/cart |
101-0050-C | ISOLUTE® 101 500 mg/6 mL | 30 | 253 USD | Add to quote/cart |
Biotage is a Global Impact Tech Company committed to solving society’s problems. We offer workflow solutions and products to customers in drug discovery and development and diagnostics, analytical testing and water and environmental testing.
Biotage is contributing to sustainable science with the goal to make the world healthier, greener and cleaner – HumanKind Unlimited.
Our customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research and contract manufacturers as well as clinical, forensic and academic laboratories in addition to organizations focused on food safety, clean water and environmental sustainability.
Biotage is headquartered in Uppsala in Sweden and employs over 500 people worldwide. The Group had sales of 1,566 MSEK in 2022 and our products are sold in more than 80 countries. Biotage’s share (BIOT) is listed in the Large Cap segment on the NASDAQ Stockholm.
Copyright © 2023 Biotage